Caduceus Biotechnology Inc. Participates in 2025 TINVA Demo Day Showcasing Innovations in Precision Medicine

Chairman Rung-Ywan Tsai (Demonstration)

On August 1, 2025, Caduceus Biotechnology Inc. was invited to participate in the TINVA Demo Day, joining innovative startups from Taiwan and around the world to showcase cutting-edge technologies and solutions. The event brought together investors, industry leaders, and entrepreneurial teams, focusing on the latest developments in smart healthcare, digital health, and emerging biomedical technologies.

At this year’s Demo Day, Caduceus highlighted its latest advancements in digital Alzheimer’s disease (AD) biomarker blood testing and shared how this technology, through precise detection and data analysis, can significantly improve the efficiency and accuracy of early disease diagnosis—attracting strong interest from attendees and investors.

The TINVA Demo Day provided an excellent platform for Caduceus to present its research and development achievements to a wider audience of international investors and strategic partners. The company will continue to deepen its focus in the field of precision medicine, integrating innovative technologies with clinical needs, driving the ongoing evolution of the health industry, and working hand in hand with global partners to create a healthier future.